VSN16R – A NOVEL TREATMENT FOR SPASTICITY IN EXPERIMENTAL MULTIPLE SCLEROSIS

Current symptomatic treatments for spasticity in multiple sclerosis often exhibit intolerable side-effects that limit their use. We synthesized a novel compound, VSN16R, which exhibited anti-spastic activity in experimental autoimmune encephalomyelitis (EAE) in mice and was as active as baclofen and...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Journal of neurology, neurosurgery and psychiatry neurosurgery and psychiatry, 2016-12, Vol.87 (12), p.e1-e1
Hauptverfasser:	Williams, Thomas, Pryce, Gareth, Giovannoni, Gavin, Selwood, David, Baker, David
Format:	Artikel
Sprache:	eng
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!